Fungal infections are on the rise, driven by a growing population at risk and climate change.
Currently available antifungals include only five classes, and their utility and efficacy in …

The growing pool of critically ill or immunocompromised patients leads to a constant
increase of life-threatening invasive infections by fungi such as Aspergillus spp., Candida …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Abstract The European Society for Clinical Microbiology and Infectious Diseases, the
European Confederation of Medical Mycology and the European Respiratory Society Joint …

These updated AST‐IDCOP guidelines provide information on epidemiology, diagnosis, and
management of Aspergillus after organ transplantation. Aspergillus is the most common …

Abstract Background Coronavirus disease 19 (COVID-19)-associated pulmonary
aspergillosis (CAPA) emerged as important fungal complications in patients with COVID-19 …

The field of cardiothoracic transplantation (CT) has evolved significantly, but infections
remain an important cause of morbidity and mortality, particularly fungal infections (FIs). The …

An improved understanding of the pathogenesis of Aspergillus infections has facilitated the
identification of host biomarkers that, if validated in well-designed prospective studies, could …

The aim of this study was to assess the outcome and tolerability of prophylactic nebulized
liposomal amphotericin B (n‐LAB) in lung transplant recipients (LTR) and the changing …

BACKGROUND Invasive aspergillosis (IA) is a frequent complication in lung transplant
recipients (LTRs). Clinical risk factors for IA have not been fully characterized, especially in …